The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Unique Forms of the abl Tyrosine Kinase Distinguish Ph 1 -Positive CML from Ph 1 -Positive ALL
Abstract
In the Philadelphia chromosome (Ph 1 ) of chronic myelogenous leukemia (CML), the c- abl gene on chromosome 9 is translocated to bcr on chromosome 22. This results in the expression of a chimeric bcr-abl message that encodes the P210 bcr-abl tyrosine kinase. The cells of 10% of acute lymphocytic leukemia patients (ALL) carry a cytogenetically similar Ph 1 translocation. We report that Ph 1 -positive ALL cells express unique abl -derived tyrosine kinases of 185 and 180 kilodaltons that are distinct from the bcr-abl -derived P210 protein of CML. The appearance of the 185/180-kilodalton proteins correlates with the expression of a novel 6.5-kilobase messenger RNA. Thus, similar genetic translocations in two different leukemias result in the expression of distinct c- abl -derived products.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ROWLEY, J. D. (1973) · Nature · doi:10.1038/243290a0 · Cited by 4,291
Fused transcript of abl and bcr genes in chronic myelogenous leukaemia
Shtivelman, E., Lifshitz, B., Gale, R. P., & Canaani, E. (1985) · Nature · doi:10.1038/315550a0 · Cited by 1,611
Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22
GROFFEN, J., STEPHENSON, J., HEISTERKAMP, N., DEKLEIN, A., BARTRAM, C., & GROSVELD, G. (1984) · Cell · doi:10.1016/0092-8674(84)90077-1 · Cited by 1,599
A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia
Klein, A. D., Kessel, A. G. V., Grosveld, G., Bartram, C. R., Hagemeijer, A., Bootsma, D., Spurr, N. K., Heisterkamp, N., Groffen, J., & Stephenson, J. R. (1982) · Nature · doi:10.1038/300765a0 · Cited by 1,378
Structural organization of the bcr gene and its role in the Ph′ translocation
Heisterkamp, N., Stam, K., Groffen, J., de Klein, A., & Grosveld, G. (1985) · Nature · doi:10.1038/315758a0 · Cited by 882
Heisterkamp, N., Stephenson, J. R., Groffen, J., Hansen, P. F., de Klein, A., Bartram, C. R., & Grosveld, G. (1983) · Nature · doi:10.1038/306239a0 · Cited by 842
The Chronic Myelogenous Leukemia-Specific P210 Protein Is the Product of the bcr / abl Hybrid Gene
Ben-Neriah, Y., Daley, G. Q., Mes-Masson, A.-M., Witte, O. N., & Baltimore, D. (1986) · Science · doi:10.1126/science.3460176 · Cited by 806
Self-citationBartram, C. R., de Klein, A., Hagemeijer, A., van Agthoven, T., van Kessel, A. G., Bootsma, D., Grosveld, G., Ferguson-Smith, M. A., Davies, T., Stone, M., et al. (1983) · Nature · doi:10.1038/306277a0 · Cited by 747
Nh, P., PHILIPS, M., & Wf, W. (1964) · PubMed · Cited by 263
Konopka, J. B., & Witte, O. N. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.11.3116 · Cited by 250
Self-citationAltered Transcription of the c- abl Oncogene in K-562 and Other Chronic Myelogenous Leukemia Cells
Collins, S. J., Kubonishi, I., Miyoshi, I., & Groudine, M. T. (1984) · Science · doi:10.1126/science.6587568 · Cited by 206
Grosveld, G., Verwoerd, T., van Agthoven, T., de Klein, A., Ramachandran, K. L., Heisterkamp, N., Stam, K., & Groffen, J. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.2.607 · Cited by 202
Konopka, J. B., Watanabe, S. M., Singer, J. W., Collins, S. J., & Witte, O. N. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.6.1810 · Cited by 156
Self-citationALTERED TRANSCRIPTION OF AN ONCOGENE IN CHRONIC MYELOID LEUKAEMIA
Canaani, E., Steiner-Salz, D., Aghai, E., Gale, R. P., Berrebi, A., & Januszewicz, E. H. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90997-8 · Cited by 153
Heterogeneity of chromosome 22 breakpoint in Philadelphia-positive (Ph+) acute lymphocytic leukemia.
Erikson, J., Griffin, C. A., ar-Rushdi, A., Valtieri, M., Hoxie, J. A., Finan, J. B., Emanuel, B. S., Rovera, G., Nowell̀, P. C., & Croce, C. M. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.6.1807 · Cited by 151
A transformation-defective mutant of Abelson murine leukemia virus lacks protein kinase activity.
Witte, O. N., Goff, S. P., Rosenberg, N. E., & Baltimore, D. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.8.4993 · Cited by 124
Self-citationMes‐Masson, A., McLaughlin, J., Daley, G. Q., Paskind, M. P., & Witte, O. N. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.24.9768 · Cited by 124
Self-citationKonopka, J. B., Davis, R. L., Watanabe, S. M., Ponticelli, A. S., Schiff-Maker, L., Rosenberg, N. E., & Witte, O. N. (1984) · Journal of Virology · doi:10.1128/jvi.51.1.223-232.1984 · Cited by 113
Self-citationAbelson murine leukemia virus mutants deficient in kinase activity and lymphoid cell transformation
Rosenberg, N. E., Clark, D. R., & Witte, O. N. (1980) · Journal of Virology · doi:10.1128/jvi.36.3.766-774.1980 · Cited by 98
Self-citationKonopka, J. B., Clark, S., McLaughlin, J., Nitta, M., Kato, Y., Strife, A., Clarkson, B., & Witte, O. N. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.11.4049 · Cited by 32
Self-citation
Cited by
Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification
Gorre, M. E., Mohammed, M., Ellwood, K., Hsu, N., Paquette, R., Rao, P. N., & Sawyers, C. L. (2001) · Science · doi:10.1126/science.1062538 · Cited by 3,104
Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene
Tybulewicz, V. L. J., Crawford, C. E., Jackson, P. K., Bronson, R. T., & Mulligan, R. C. (1991) · Cell · doi:10.1016/0092-8674(91)90011-m · Cited by 1,281
Tyrosine Kinase Activity and Transformation Potency of bcr-abl Oncogene Products
Lugo, T. G., Pendergast, A.-M., Muller, A. J., & Witte, O. N. (1990) · Science · doi:10.1126/science.2408149 · Cited by 1,281
Self-citationvan Dongen, J., Macintyre, E., Gabert, J., Delabesse, E., Rossi, V, Saglio, G., Gottardi, E., Rambaldi, A., Dotti, G., Griesinger, F., et al. (1999) · Leukemia · doi:10.1038/sj.leu.2401592 · Cited by 1,169
Inaba, H., Greaves, M., & Mullighan, C. G. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62187-4 · Cited by 1,074
Metadata
- Authors
- Clark, S. S., McLaughlin, J., Crist, W. M., Champlin, R., & Witte, O. N.
- Venue
- Science
- Published
- 1987-01-02
- Volume
- 235
- Issue
- 4784
- Pages
- 85-88
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2040323778
- Cited by
- 320
- References
- 20
- FWCI
- 23.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.